Welcome to our dedicated page for 111 SEC filings (Ticker: YI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The 111, Inc. (NASDAQ: YI) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer. 111, Inc. furnishes current reports on Form 6-K under the Securities Exchange Act of 1934, which include exhibits such as unaudited quarterly financial results. Recent 6-K filings have attached press releases for the first, second, and third quarters of 2025, outlining segment performance, operating expenses, cash flow, and the company’s use of non-GAAP financial measures.
Through these filings, investors can review details of 111, Inc.’s B2B and B2C segments, including net revenues, cost of products sold, and gross segment profit. The filings also explain how the company calculates non-GAAP income from operations, non-GAAP net income or loss, non-GAAP net loss attributable to ordinary shareholders, and non-GAAP loss per ADS by excluding share-based compensation expenses, net of tax, from the corresponding GAAP metrics. Each filing includes a discussion of the limitations of these measures and reconciliations to the most comparable GAAP figures.
Filings may also reference liquidity and capital structure topics, such as cash, cash equivalents, restricted cash, short-term investments, and obligations to investors in 1 Pharmacy Technology that are recorded as redeemable non-controlling interests and accrued liabilities. These disclosures help readers understand the company’s financial position and obligations as part of its tech-enabled healthcare platform operations in China.
On Stock Titan, 111, Inc.’s filings are updated as new documents are released through EDGAR. AI-powered tools summarize key points from lengthy filings, highlight segment trends, and surface important definitions and reconciliations for non-GAAP metrics. Users can quickly scan new 6-Ks for changes in operating performance, cash flow, and strategic commentary, while still having access to the full original documents for deeper analysis.
111, Inc. (YI) disclosures show a company managing liquidity through multiple bank credit facilities and operational measures while reporting improving cash generation. The Group had positive operating cash flows of RMB 263,016 for the year ended December 31, 2024 and maintained a Master Guarantee Facility with RMB 100,000 committed (RMB 50,000 undrawn at issuance). Additional facilities include a credit line up to RMB 30,000 expiring January 2026 and other working-capital arrangements drawn and repaid during 2023–2024.
Other disclosures note segment reporting for B2C and B2B, treatment of marketplace revenue as principal/agent, reverse factoring outstanding RMB nil in 2024 (was RMB 98,109 in 2023), share-based plans and repurchases at subsidiary level, and restricted PRC subsidiary capital of RMB 618,830 and RMB 639,000 not available for distribution.
FAQ
What is the current stock price of 111 (YI)?
What is the market cap of 111 (YI)?
